JP2005507381A5 - - Google Patents

Download PDF

Info

Publication number
JP2005507381A5
JP2005507381A5 JP2003523181A JP2003523181A JP2005507381A5 JP 2005507381 A5 JP2005507381 A5 JP 2005507381A5 JP 2003523181 A JP2003523181 A JP 2003523181A JP 2003523181 A JP2003523181 A JP 2003523181A JP 2005507381 A5 JP2005507381 A5 JP 2005507381A5
Authority
JP
Japan
Prior art keywords
acid
dibromo
isopropyl
hydroxy
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003523181A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005507381A (ja
Filing date
Publication date
Priority claimed from GB0120691A external-priority patent/GB0120691D0/en
Priority claimed from GB0207719A external-priority patent/GB0207719D0/en
Application filed filed Critical
Priority claimed from PCT/EP2002/009120 external-priority patent/WO2003018515A2/en
Publication of JP2005507381A publication Critical patent/JP2005507381A/ja
Publication of JP2005507381A5 publication Critical patent/JP2005507381A5/ja
Pending legal-status Critical Current

Links

JP2003523181A 2001-08-24 2002-08-13 心臓障害および代謝障害の治療のための主要環置換甲状腺受容体アンタゴニスト Pending JP2005507381A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0120691A GB0120691D0 (en) 2001-08-24 2001-08-24 Novel Compounds
GB0207719A GB0207719D0 (en) 2002-04-03 2002-04-03 Novel compounds
PCT/EP2002/009120 WO2003018515A2 (en) 2001-08-24 2002-08-13 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders

Publications (2)

Publication Number Publication Date
JP2005507381A JP2005507381A (ja) 2005-03-17
JP2005507381A5 true JP2005507381A5 (cg-RX-API-DMAC7.html) 2006-06-22

Family

ID=26246475

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003523181A Pending JP2005507381A (ja) 2001-08-24 2002-08-13 心臓障害および代謝障害の治療のための主要環置換甲状腺受容体アンタゴニスト

Country Status (8)

Country Link
US (1) US7279593B2 (cg-RX-API-DMAC7.html)
EP (1) EP1499578A2 (cg-RX-API-DMAC7.html)
JP (1) JP2005507381A (cg-RX-API-DMAC7.html)
KR (1) KR20040027927A (cg-RX-API-DMAC7.html)
AU (1) AU2002331145B2 (cg-RX-API-DMAC7.html)
CA (1) CA2449515A1 (cg-RX-API-DMAC7.html)
IL (1) IL159006A0 (cg-RX-API-DMAC7.html)
WO (1) WO2003018515A2 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL160845A0 (en) * 2001-09-14 2004-08-31 Tularik Inc Linked biaryl compounds
EP2428516A1 (en) 2003-11-19 2012-03-14 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
GB0406380D0 (en) * 2004-03-22 2004-04-21 Karobio Ab Novel pharmaceutical compositions
US20090232879A1 (en) 2005-05-26 2009-09-17 Metabasis Therapeutics, Inc. Thyromimetics for the Treatment of Fatty Liver Diseases
KR101396606B1 (ko) 2009-04-20 2014-05-16 미쓰비시 타나베 파마 코퍼레이션 신규 갑상선 호르몬 β 수용체 작동약
WO2018094265A2 (en) 2016-11-21 2018-05-24 Viking Therapeutics, Inc. Method of treating glycogen storage disease
AU2018280118B2 (en) 2017-06-05 2021-07-15 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
EP3683306A4 (en) 2017-09-14 2021-06-09 Riken METHOD FOR MANUFACTURING RETINAGE TISSUE
EA202091979A1 (ru) 2018-03-22 2021-06-22 Вайкинг Терапьютикс, Инк. Кристаллические формы и способы получения кристаллических форм соединения
EP4775207A2 (en) 2018-12-05 2026-07-15 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
SG11202109855PA (en) 2019-03-13 2021-10-28 Sumitomo Dainippon Pharma Co Ltd Method for evaluating quality of transplant neural retina, and transplant neural retina sheet
EP4161925A4 (en) 2020-06-09 2024-09-04 Viking Therapeutics, Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISEASES
JPWO2022054925A1 (cg-RX-API-DMAC7.html) 2020-09-11 2022-03-17
EP4201428A4 (en) 2020-09-11 2024-09-11 Sumitomo Pharma Co., Ltd. MEDIUM FOR TISSUE INTENDED FOR TRANSPLANTATION
KR20240103018A (ko) 2021-11-19 2024-07-03 고쿠리쓰 겐큐 가이하쓰 호징 리가가쿠 겐큐소 시트상 망막 조직의 제조 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8501372D0 (en) 1985-01-18 1985-02-20 Smith Kline French Lab Chemical compounds
EP0580550B1 (en) * 1992-07-21 1997-10-22 Novartis AG Oxamic acid derivatives as hypocholesteremic agents
JPH11508241A (ja) 1995-06-07 1999-07-21 カロ バイオ エービー 甲状腺ホルモンまたは甲状腺ホルモン様化合物に関する新規な使用
GB9713739D0 (en) 1997-06-27 1997-09-03 Karobio Ab Thyroid receptor ligands
GB9816935D0 (en) * 1998-08-05 1998-09-30 Karobio Ab Novel glucocortoid and thyroid receptor ligands for the treatment of metabolic disorders
GB9828442D0 (en) 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
GB9927056D0 (en) 1999-11-17 2000-01-12 Karobio Ab Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
KR20020089420A (ko) 2000-03-31 2002-11-29 화이자 프로덕츠 인코포레이티드 갑상선 수용체 리간드로서의 말로남산 및 그의 유도체
AU4884701A (en) 2000-05-12 2001-11-20 Kissei Pharmaceutical Co. Ltd. Malonanilic acid derivatives, medicinal compositions containing the same and usethereof

Similar Documents

Publication Publication Date Title
JP2005522476A5 (cg-RX-API-DMAC7.html)
JP2004533450A5 (cg-RX-API-DMAC7.html)
JP2020075939A5 (cg-RX-API-DMAC7.html)
JP2004529174A5 (cg-RX-API-DMAC7.html)
JP2007502806A5 (cg-RX-API-DMAC7.html)
JP2017504642A5 (cg-RX-API-DMAC7.html)
JP2019537605A5 (cg-RX-API-DMAC7.html)
CA2683738A1 (en) Indanone derivatives that inhibit prolyl hydroxylase
JP2005528393A5 (cg-RX-API-DMAC7.html)
JP2014502972A5 (cg-RX-API-DMAC7.html)
JP2017507915A5 (cg-RX-API-DMAC7.html)
JP2004534824A5 (cg-RX-API-DMAC7.html)
RU2006119510A (ru) Фенильные производные в качестве ppar агонистов
RU2003134150A (ru) Замещенные карбоновыми кислотами оксазоловые производные в качестве ppar-альфа и гамма-активаторов при лечении диабета
JP2007502265A5 (cg-RX-API-DMAC7.html)
JP2013531070A5 (cg-RX-API-DMAC7.html)
RU2006107653A (ru) Связующее вспомогательное вещество и приготовленная на его основе таблетка в форме капли
RU2010129541A (ru) Карбоксил- или гидроксилзамещенные производные бензимидазола
JP2010530881A5 (cg-RX-API-DMAC7.html)
JP2020504120A5 (cg-RX-API-DMAC7.html)
JP2005521721A5 (cg-RX-API-DMAC7.html)
JP2008512408A5 (cg-RX-API-DMAC7.html)
JP2018525371A5 (cg-RX-API-DMAC7.html)
RU2007106868A (ru) Оксазол-нафтиловые кислоты и их применение в качестве модуляторов ингибитора активатора плазминогена-1 (pai) для лечения тромбоза и сердечно-сосудистых заболеваний
JP2007515467A5 (cg-RX-API-DMAC7.html)